In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram- positive and gram-negative pathogens from respiratory tract infections (Q73807258)
scientific article published on 01 September 1997
Language:
Current Data About In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram- positive and gram-negative pathogens from respiratory tract infections
(P31) (Q13442814)
(P248)
(P698) 9338498
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338498%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

(P304) 427-431
(P248)
(P698) 9338498
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338498%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

(P407) (Q1860)

(P433) 3
(P248)
(P698) 9338498
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338498%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

(P478) 40
(P248)
(P698) 9338498
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338498%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

(P577) Monday, September 1, 1997
(P248)
(P698) 9338498
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338498%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

Monday, September 1, 1997
(P248)
(P698) 9338498
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9338498
(P813) Wednesday, November 20, 2024

(P921) (Q424193)
(P887)

(Q754447)
(P887)

(P953) https://academic.oup.com/jac/article-pdf/40/3/427/9837793/400427.pdf
(P2701)
(P6954)
(P248)
(P698) 9338498
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9338498
(P813) Wednesday, November 20, 2024

http://academic.oup.com/jac/article-pdf/40/3/427/9837793/400427.pdf
(P2701)
(P248)
(P356) 10.1093/JAC/40.3.427
(P854) https://api.crossref.org/works/10.1093/JAC/40.3.427
(P813) Wednesday, November 20, 2024

(P1433) (Q6294770)
(P248)
(P698) 9338498
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338498%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

(P1476) "In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections" (language: en)
(P248)
(P698) 9338498
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338498%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, November 6, 2019

"In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram- positive and gram-negative pathogens from respiratory tract infections" (language: en)
(P248)
(P356) 10.1093/JAC/40.3.427
(P854) https://api.crossref.org/works/10.1093/JAC/40.3.427
(P813) Wednesday, November 20, 2024

(P2093) J. A. Hoogkamp-Korstanje
(P1545) 1
(P248)
(P698) 9338498
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9338498
(P813) Wednesday, November 20, 2024

other details
description scientific article published on 01 September 1997

External Links
(P356) 10.1093/JAC/40.3.427
(P698) 9338498